News
During a live event, Hari Deshpande, MD, and participants discussed the DeFi trial and the management of nirogacestat in ...
AstraZeneca, Pfizer and more are leveraging the computational power of AI to better design trials, predict the potential ...
New data shed light on the best strategies for managing patients who develop interstitial lung disease while being treated ...
AstraZeneca (NASDAQ:AZN) is one of the 8 Best Inexpensive Stocks to Buy Right Now. On June 9, the first patient was dosed by ...
Relacorilant plus nab-paclitaxel improved PFS and showed a trend toward longer OS in platinum-resistant ovarian cancer in ROSELLA.
Researchers evaluated current treatment patterns and clinical outcomes for patients with HER2-positive metastatic breast cancer.
In June 2025, AstraZeneca announced a Phase III study to determine the efficacy and safety of durvalumab + tremelimumab ...
Novellia, Inc., the AI health data platform trusted by leading biopharma companies to uncover hidden insights in real-world patient data, today announced that its CEO and co-founder Shashi Shankar has ...
A supplemental podcast curriculum improved hematology-oncology fellows’ comfort with and knowledge of medical topics, according to study results presented at ASCO Annual Meeting.The findings support ...
Pyxis Oncology Inc. research and ratings by Barron's. View PYXS revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.
Worldwide Healthcare Trust PLC - Annual Financial Report PR Newswire LONDON, United Kingdom, June 11 10 June 2025Worldwide Healthcare Trust PLC(the "Company") Annual Financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results